Engraftment of Human Primary Acute Myeloid Leukemia Defined by Integrated Genetic Profiling in NOD/SCID/IL2rγnull Mice for Preclinical Ceramide-Based Therapeutic Evaluation

Acute Myeloid Leukemia (AML) is a highly heterogeneous and poor prognosis disease with few available therapeutic options. Novel advances are urgently needed, however effective models to test experimental therapeutics have been lacking. Recently, NOD/SCID/IL2rγnull (NSG) mice were shown to engraft pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Barth, Brian M, Keasey, Nichole R, Wang, Xujung, Shanmugavelandy, Sriram S, Rampal, Raajit, Hricik, Todd, Cabot, Myles C, Kester, Mark, Wang, Hong-Gang, Shultz, Leonard D, Tallman, Martin S, Levine, Ross L, Loughran, Thomas P, Claxton, David F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321614/
https://www.ncbi.nlm.nih.gov/pubmed/28239612
http://dx.doi.org/10.4172/2329-6917.1000146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321614/
https://www.ncbi.nlm.nih.gov/pubmed/28239612
http://dx.doi.org/10.4172/2329-6917.1000146

Ejemplares similares